ABSTRACT
Adenosine kinase (AK) is a purine salvage enzyme that catalyzes the phosphorylation of adenosine to AMP. In
Mycobacterium tuberculosis
, AK can also catalyze the phosphorylation of the adenosine analog 2-methyladenosine (methyl-Ado), the first step in the metabolism of this compound to an active form. Purification of AK from
M. tuberculosis
yielded a 35-kDa protein that existed as a dimer in its native form. Adenosine (Ado) was preferred as a substrate at least 30-fold (
K
m
= 0.8 ± 0.08 μM) over other natural nucleosides, and substrate inhibition was observed when Ado concentrations exceeded 5 μM.
M. tuberculosis
and human AKs exhibited different affinities for methyl-Ado, with
K
m
values of 79 and 960 μM, respectively, indicating that differences exist between the substrate binding sites of these enzymes. ATP was a good phosphate donor (
K
m
= 1100 ± 140 μM); however, the activity levels observed with dGTP and GTP were 4.7 and 2.5 times the levels observed with ATP, respectively.
M. tuberculosis
AK activity was dependent on Mg
2+
, and activity was stimulated by potassium, as reflected by a decrease in the
K
m
and an increase in
V
max
for both Ado and methyl-Ado. The N-terminal amino acid sequence of the purified enzyme revealed complete identity with Rv2202c, a protein currently classified as a hypothetical sugar kinase. When an AK-deficient strain of
M. tuberculosis
(SRICK1) was transformed with this gene, it exhibited a 5,000-fold increase in AK activity compared to extracts from the original mutants. These results verified that the protein that we identified as AK was coded for by
Rv2202c.
AK is not commonly found in bacteria, and to the best of our knowledge,
M. tuberculosis
AK is the first bacterial AK to be characterized. The enzyme shows greater sequence homology with ribokinase and fructokinase than it does with other AKs. The multiple differences that exist between
M. tuberculosis
and human AKs may provide the molecular basis for the development of nucleoside analog compounds with selective activity against
M. tuberculosis
.
摘要
腺苷激酶(AK)是一种
嘌呤挽救酶,可催化
腺苷磷酸化为
AMP。在
结核分枝杆菌中
中,AK 还能催化
腺苷类似物
2-甲基腺苷(甲基-Ado)的
磷酸化,这是这种化合物代谢为活性形式的第一步。从
结核杆菌
得到了一种 35 kDa 蛋白质,其原生形式为二聚体。
腺苷(Ado)作为底物的优先级至少提高了 30 倍 (
K
m
= 0.8 ± 0.08 μM),当 Ado 浓度超过 5 μM 时,底物抑制作用就会出现。
结核杆菌
和人类 AK 对甲基-Ado 表现出不同的亲和力,其中
K
m
值分别为 79 μM 和 960 μM,表明这些酶的底物结合位点之间存在差异。
ATP 是一种良好的
磷酸盐供体 (
K
m
= 1100 ± 140 μM);然而,用 dGTP 和 GTP 观察到的活性
水平分别是用
ATP 观察到的活性
水平的 4.7 倍和 2.5 倍。
结核杆菌
AK 活性取决于 Mg
2+
钾对其活性有刺激作用。
K
m
的降低和
V
最大值
增加。纯化酶的 N 端
氨基酸序列显示与 Rv2202c 蛋白完全一致,后者目前被归类为假定的糖激酶。当一株 AK 缺失的
结核杆菌
(SRICK1)时,其 AK 活性比原始突变体的
提取物提高了 5000 倍。这些结果验证了我们确定的 AK 蛋白是由
Rv2202c 所编码。
据我们所知,AK 在细菌中并不常见、
结核杆菌
AK 是第一个被鉴定的细菌 AK。与其他 AK 相比,该酶与
核糖激酶和
果糖激酶的序列同源性更高。与其他 AK 相比,结核杆菌 AK 与
核糖激酶和
果糖激酶的序列同源性更高。
结核杆菌
和人类 AK 之间存在的多种差异可能为开发对结核杆菌具有选择性活性的核苷类似物提供了分子基础。
结核杆菌
.